Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
HSCS US​

HeartSciences Inc.(HSCS US)

$3.14-0.030.95%Ext:$3.25+0.113.50%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(18)

Expand
  • 10-QQ1ended 31 Jul 202614 Sep
  • 10-KFY 2026ended 30 Apr 202623 Jul
  • 10-QQ3ended 31 Jan 202616 Mar
  • 10-QQ2ended 31 Oct 202515 Dec 2025
  • 10-QQ1ended 31 Jul 202511 Sep 2025
  • 10-KFY 2025ended 30 Apr 202524 Jul 2025
  • 10-QQ3ended 31 Jan 202513 Mar 2025
  • 10-QQ2ended 31 Oct 202416 Dec 2024
  • 10-QQ1ended 31 Jul 202412 Sep 2024
  • 10-KFY 2024ended 30 Apr 202429 Jul 2024
  • 10-QQ3ended 31 Jan 202414 Mar 2024
  • 10-QQ2ended 31 Oct 202314 Dec 2023
  • 10-QQ1ended 31 Jul 202314 Sep 2023
  • 10-KFY 2023ended 30 Apr 202319 Jul 2023
  • 10-QQ3ended 31 Jan 202316 Mar 2023

Events(100)

Expand
  • 8-KPRESS RELEASE, DATED OCTOBER 6, 20266 Oct
  • 8-KEntry into a Material Definitive Agreement2 Oct
  • 8-KPRESS RELEASE, DATED SEPTEMBER 17, 2026.17 Sep
  • 8-KPRESS RELEASE DATED SEPTEMBER 15, 202615 Sep
  • 8-KPRESS RELEASE, DATED AUGUST 20, 2026.20 Aug
  • 8-K/AUNAUDITED INTERIM FINANCIAL STATEMENTS OF FORTITUDE AS OF AND FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025, AND THE ACCOMPANYING NOTES19 Aug
  • 8-KPRESS RELEASE, DATED AUGUST 19, 202619 Aug
  • 8-KEntry into a Material Definitive Agreement18 Aug
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing7 Aug
  • 8-KPRESS RELEASE, DATED JULY 29, 202629 Jul
  • 8-K/AAUDITED FINANCIAL STATEMENTS OF FORTITUDE AS OF AND FOR THE FISCAL YEARS ENDED DECEMBER 31, 2025 AND 2024, AND THE ACCOMPANYING NOTES27 Jul
  • 8-KEntry into a Material Definitive Agreement27 Jul
  • 8-KPRESS RELEASE, DATED JULY 23, 202623 Jul
  • 8-KUnregistered Sales of Equity Securities10 Jul
  • 8-KUnregistered Sales of Equity Securities26 Jun

Insider Ownership(35)

Expand
  • 4Watson Danielle9 Jul
  • 4Simpson Andrew24 Jun
  • 4Wells David R.12 Jan
  • 4Bent Bruce12 Jan
  • 4HILZ MARK T22 Dec 2025
  • 4Szymczak Brian22 Dec 2025
  • 4Watson Danielle22 Dec 2025
  • 4Simpson Andrew28 Nov 2025
  • 4HILZ MARK T30 Jul 2025
  • 4Bent Bruce14 Jul 2025
  • 4Szymczak Brian11 Jul 2025
  • 4Simpson Andrew11 Jul 2025
  • 4Wells David R.11 Jul 2025
  • 4HILZ MARK T11 Jul 2025
  • 4Watson Danielle11 Jul 2025

Beneficial Ownership(9)

Expand
  • SC 13D/AHeartSciences Inc.23 Oct
  • SC 13DHeartSciences Inc.18 Aug
  • SC 13GHeartSciences Inc.24 Jun
  • SC 13GHeart Test Laboratories, Inc.11 Dec 2023
  • SC 13GHeart Test Laboratories, Inc.27 Nov 2023
  • SC 13DHeart Test Laboratories, Inc.14 Jun 2023
  • SC 13DHeart Test Laboratories, Inc.14 Jun 2023
  • SC 13GHeart Test Laboratories, Inc.10 Mar 2023
  • SC 13GHeart Test Laboratories, Inc.10 Mar 2023

Other Ownership(1)

Expand
  • 144HILZ MARK T29 Jul 2025

Proxies(74)

Expand
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS21 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS19 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS19 Oct
  • DEFM14APROXY STATEMENT19 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS15 Oct
  • DEFA14ACURRENT REPORT6 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS6 Oct
  • PRER14APROXY SATEMENT5 Oct
  • DEFA14ACURRENT REPORT2 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS30 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS24 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS21 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS18 Sep
  • PRER14APROXY STATEMENT17 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS17 Sep

Registrations(48)

Expand
  • 424B5PROSPECTUS SUPPLEMENT9 Oct
  • S-3REGISTRATION STATEMENT25 Sep
  • S-8REGISTRATION STATEMENT25 Aug
  • S-8REGISTRATION STATEMENT5 Nov 2025
  • 424B5PROSPECTUS SUPPLEMENT4 Aug 2025
  • RWWITHDRAWAL REQUEST19 Dec 2024
  • RWWITHDRAWAL LETTER17 Dec 2024
  • S-1/AREGISTRATION STATEMENT27 Sep 2024
  • 424B3PROSPECTUS18 Mar 2024
  • S-1REGISTRATION STATEMENT5 Mar 2024
  • S-8REGISTRATION STATEMENT26 Feb 2024
  • 424B5PROSPECTUS17 Nov 2023
  • 424B5PROSPECTUS13 Nov 2023
  • S-1/AREGISTRATION STATEMENT16 Oct 2023
  • 424B5Prospectus filing (Rule 424(b)(5))4 Oct 2023

Filing Review Correspondence(12)

Expand
  • CORRESPFiling review correspondence6 Mar 2025
  • CORRESPFiling review correspondence12 Mar 2024
  • CORRESPFiling review correspondence26 Sep 2023
  • CORRESPFiling review correspondence6 Apr 2023
  • CORRESPFiling review correspondence6 Oct 2022
  • CORRESPFiling review correspondence13 Jun 2022
  • CORRESPFiling review correspondence13 Jun 2022
  • CORRESPFiling review correspondence10 Jun 2022
  • CORRESPFiling review correspondence10 Jun 2022
  • CORRESPFiling review correspondence6 Jun 2022
  • CORRESPFiling review correspondence17 May 2022
  • DRSLTRFiling review correspondence (DRSLTR)19 Apr 2022

SEC Orders And Notices(7)

Expand
  • QUALIFQualification notice20 Apr
  • QUALIFQualification notice10 Mar 2025
  • EFFECTNotice of effectiveness13 Mar 2024
  • EFFECTNotice of effectiveness28 Sep 2023
  • EFFECTNotice of effectiveness10 Apr 2023
  • EFFECTNotice of effectiveness7 Oct 2022
  • EFFECTNotice of effectiveness14 Jun 2022

Exempt Offerings(21)

Expand
  • 253G2OFFERING CIRCULAR1 Jun
  • 253G2OFFERING CIRCULAR17 Apr
  • 1-A POSPOST EFFECTIVE AMENDMENT NO. 1 TO FORM 1-A10 Apr
  • 253G2OFFERING CIRCULAR SUPPLEMENT15 May 2025
  • 253G2OFFERING CIRCULAR SUPPLEMENT11 Mar 2025
  • 1-A/AOffering statement (Regulation A, amendment)3 Mar 2025
  • 1-AOffering statement (Regulation A)12 Feb 2025
  • D06b7 Dec 2023
  • D/A06b7 Dec 2023
  • D06b4 Dec 2023
  • D06b20 Sep 2023
  • D06b28 Dec 2021
  • D06b15 Oct 2021
  • DNotice of exempt offering of securities (Reg D)19 Feb 2021
  • D06b11 Dec 2019

Other(1)

Expand
  • CERTCERT14 Jun 2022

Financials & Metrics

FinancialsChartingShort InterestEmployees